Breaking News, Financial News

Financial Report: INC Research

Revenues up 29% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

INC Research 4Q Revenues: $327.7 million (+29%) 4Q Loss: $49.8 million (loss of $13 million 4Q13) FY Revenues: $1.2 billion (+18%) FY Loss: $23.4 million (loss of $41.5 million FY13) Comments: Service revenue increased 23% in the quarter to $213.7 million. Net new business awards were $316.3 million, representing growth of 11% and a book-to-bill ratio of 1.5x....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters